“The service is available to clients of all sizes, although it may prove most beneficial to small businesses that typically lack the administrative staff needed to manage a wellness program, said Aaron MacDonald, Blue Cross Blue Shield’s director of small group sales and external distribution.
MacDonald described WebMD Health Services, a unit of WebMD Health Corp., as a “turnkey solution” that’s readily adopted by employers.”
According to the U.S. Census Bureau, Bureau of Labor Statistics, there are 27.9 million small businesses in the U.S.
Over 50% of the working population (120 million individuals) works in a small business
Small businesses have generated over 65% of the net new jobs since 1995
Approximately 543,000 new businesses get started each month (but more employer businesses shut down than start up each month)
I find the fact that WBMD has a “turnkey solution” that's readily adopted by 27.9 million potential clients very interesting.
Insurance providers offer options to help small employers adopt wellness programs
Blue Cross Blue Shield of Michigan’s partnership with an arm of WebMD Health Corp. could help to extend wellness into an area where it’s gained the least traction: small businesses.
The service is available to clients of all sizes, although it may prove most beneficial to small businesses that typically lack the administrative staff needed to manage a wellness program, said Aaron MacDonald, Blue Cross Blue Shield’s director of small group sales and external distribution.
MacDonald described WebMD Health Services, a unit of WebMD Health Corp., as a “turnkey solution” that’s readily adopted by employers.
Interesting news coming out of JNJ
More than 10 new drugs till 2019
New anti-cancer drug
This should heat up the whole industry including WBMD
Its all a question of timing.
First you increase the audience, then comes the increase in revenues.
After all, those who want to sell something, have to go, where their clients are.
In other words, the big increases in WBMD's audience today should result in big increases in its revenues tomorrow.
This is so simple, it should be obvious to everybody – without increased guidance by the company.
Agreed. However, they also announced this very important news:
“Recently, we entered into an agreement with Carenet, one of the leading websites for healthcare professionals in Japan. Medscape will provide its independent educational programs and editorial content to physicians in Japan on a Medscape-branded area of the Carenet site. Offering Medscape’s leading medical education and editorial resources to Japanese healthcare professionals in their local language extends our global reach in this important market, which is one of the largest pharmaceutical markets in the world behind the U.S.”
Should that not create a little bit of excitement?
It seems to me only some of the old professionals, like the guys at Elkcreekpartners, are still able to see beyond their noses. They just filed WBMD as their second largest position.
I just wonder who it is who wants the stock to stay put where it is now.
Every day the same trading pattern: First it goes up, then its pushed back down.
The market makers must have a lot of fun...
From the last earnings conference:
Turning to Information Services, our Information Services comprise standalone data products that we sell to data services, informatics, and consulting companies. Revenue from the sale of Information Services in the first quarter increased 32% from $6.2 million to $8.2 million. The principal source of the data that we use in these Information Services is from a 10-year license to de-identify data that we retained from our divestiture of Emdeon Business Services in 2008.
We are currently working on bringing in new third-party data sources to both strengthen and diversify our data products, and in anticipation of the expiration of the Emdeon license.
I've always been under the impression that at the time of the divestiture of Emdeon, WBMD had an agreement of indefenite access to their data, which to me means no time limite.
Now they are talking about a 10 year agreement.
Anybody remembers the deal?
An interesting item is Information Services Revenue, which shows an increase of 32%.
In that context, I recommend reading the recent article by Trevir Nath “How Big Data Has Changed Healthcare”
Leerink Swann restated their outperform rating on stock of WebMD Health Corp. (NASDAQ:WBMD) in a report issued on Saturday. They currently have a $54.00 target price on the stock.
“We believe that WebMD is well positioned to capitalize on the growth and major changes that are affecting the healthcare industry and that are making WebMD’s core assets – the leading online audience of healthcare consumers and physicians in the US health information marketspace – increasingly valuable.,” the firm’s analyst commented.
WebMD Deserves Fees In Failed Patent Case, Judge Says
By Ryan Davis
Law360, New York (April 22, 2015, 7:51 PM ET) -- A California federal judge has ruled that WebMD Health Corp. and Allscripts Healthcare Solutions Inc. are entitled to attorneys' fees after prevailing in a patent case against them by MyMedicalRecords Inc., even though he held the case does not qualify as exceptional.
U.S. District Judge Otis Wright II of the Central District of California ruled Monday that MyMedicalRecords' conduct during the case as a whole was not exceptional under the U.S. Supreme Court's Octane Fitness fee-shifting standard, but held that the company "willfully disobeyed" his orders....
Another great occasion for the manipulators to step in and make some profit.
Chinese regulations? Greek problems?
Is that what’s important to the U.S economy?
What a lot of nonsense!
We don’t know, as we don’t know the details of their partnership agreement. However, in their original announcement there was this sentence:
“Additionally, visitors to WebMD will be able to easily use Walgreens' prescription refill and clinic appointment scheduling options from within the WebMD site on their desktop or mobile device”
“In April 2012, Express Scripts completed a $29.1 billion acquisition of Medco Health Solutions. The acquisition positioned Express Scripts Holding Co. as the largest pharmacy benefit manager, filling 1.4 billion annual prescriptions.
Medco was originally founded as National Pharmacies in 1983. In 1984, after an IPO, National Pharmacies became Medco Containment Services, LLC. In 1993, Medco Containment was acquired by Merck & Co., Inc. and became Merck-Medco. In August 2003, Medco Health Solutions, Inc. became an independent company in one of the largest domestic spin-offs at the time.”
And we all know who founded Medco….
Walgreens Boots Alliance Inc.’s acting Chief Executive Officer Stefano Pessina isn’t being shy about his ambitions to do more deals, mere months after taking the helm of the biggest U.S. drugstore chain.
On a conference call with analysts Thursday, he outlined options that include a buyout of a company in the drug-distribution supply chain or a joint venture with a partner. Express Scripts Holding Co.’s shares closed up 4.9 percent to $88.47, a record, in New York, as investors interpreted Pessina’s deal comments as a possible overture for the drug-benefits provider, Evercore ISI analyst Ross Muken said.
Walgreens is the only major U.S. retail pharmacy chain that doesn’t own a pharmacy benefit manager like Express Scripts. Such companies negotiate with drugmakers on prices for medications obtained through insurance coverage. CVS Health Corp. bought Caremark RX Inc. in 2007 to enter the business, and Rite Aid Corp. agreed this year to acquire EnvisionRX.
Express Scripts spokesman David Whitrap declined to comment. Walgreens shares rose 5.6 percent to $92.62.
The market appears ripe for another round of consolidation to take costs out of the complicated drug distribution business in the U.S., Pessina told investors on the call after the company reported second-quarter earnings that beat analysts’ estimates.
“The complex structure of delivering the medicines to the patients will have to be rationalized, and as a consequence it’s easy to believe we will have additional synergies coming from M&A activities,” he said. “We want to be -- as we have been in the past -- at the forefront of changes and so if these needs for consolidation will be confirmed, we will try to be part of it.”
His comments may indicate Walgreens is leaning more toward a deal in the industry of buying and distributing drugs than toward a merger with a direct competitor like Rite Aid, which has been the subject of speculation in recent weeks. Walgreens said Thursday it will close 200 U.S. stores this year to cut costs, throwing cold water on the idea that Pessina is eager to gain more locations.
One hint into Pessina’s strategy is the strategic relationship Walgreens entered in 2013 with AmerisourceBergen Corp., the second-biggest U.S. drug distributor. On the conference call Thursday, the acting CEO cited the alliance, which gave Walgreens the option to acquire a minority stake in the distributor, as an example of the type of “innovative partnership” he’d like to do.
“They’re rationalizing their own store base, they’re loving the deal they did with AmerisourceBergen and they’re talking about enhancing the supply chain with M&A,” said Tony Scherrer, director of research at Seattle-based Smead Capital Management, which oversees $1.4 billion and owns Walgreens stock. “If they’re doing that, then perhaps a Rite Aid deal would be less likely than what people had been thinking.”
Walgreens spent $15.3 billion to buy the rest of Alliance Boots in August, after previously controlling about 45 percent of the Swiss company. Pessina built Alliance Boots through more than three decades of mergers before selling it to Walgreens.
While the integration of the two companies continues, it won’t prevent the company from doing more deals, Pessina said. Deals or joint ventures typically take months to come to fruition anyway, he said. Walgreens executives said mergers are a top priority for the company’s cash.
While he hunts for deals, Pessina is also looking for a new leader for Walgreens. The company announced in December its CEO Greg Wasson, 56 at the time, would retire upon the closing of the deal. Pessina, who is also executive vice chairman and the biggest shareholder of Walgreens, is acting CEO while the company selects Wasson’s replacement.
I think we’ll get some more information before that.
The 1st quarter earnings conference might be used for that as they should inform on the progress of that relationship.
Executive Vice Chairman and Acting CEO Stefano Pessina said, “This quarter marked a solid start for our new company, and I remain as optimistic as ever about our long-term future. At the same time, we understand the work that is needed to proactively address headwinds such as reimbursement pressure and competition. Our work includes several key areas of focus to create value.
“The first area is improving the performance of our businesses worldwide with an emphasis on operations. Second, we will be refreshing and reinvesting in the stores of our Retail Pharmacy USA division to improve the customer experience and expand retail margins. Third, we are restructuring our cost base, with a focus primarily in the USA, to create a more efficient cost model and become a more agile company. Through these efforts, Walgreens Boots Alliance is determined to lead the way in our industry and be at the forefront of innovative, pharmacy-led health care.”